Global AAV Vector CDMO Services Supply, Demand and Key Producers, 2023-2029

Global AAV Vector CDMO Services Supply, Demand and Key Producers, 2023-2029


The global AAV Vector CDMO Services market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Adeno-associated virus (AAV) belongs to the family Parvoviridae, and its genome is approximately 4.8 kb of single-stranded DNA, non-enveloped. Only with the help of helper viruses such as adenovirus or herpesvirus, the host can produce infectious AAV (adeno-associated virus).

The recombinant adeno-associated virus vector (rAAV) used in the research field is a gene vector modified from non-pathogenic wild-type AAV. There are multiple serotypes of AAV. The main difference between AAV vectors of different serotypes is the capsid protein. The protein structures of different capsid proteins bind to different extracellular receptor molecules, so different serotypes have different targeting affinities to tissues or organs. Generally speaking, AAV has 12 serotypes and more than 100 variants. Due to its high safety, low immunogenicity, and long expression cycle, AAV is known as the most suitable tool for studying gene function in vivo.

AAV (Adeno-Associated Virus) vector CDMO service refers to a service provided by biotechnology companies in the field of gene therapy and vaccine development, providing customers with comprehensive technical support from AAV vector construction, production to purification. By using AAV vector CDMO services, customers can focus on the core scientific issues of gene therapy and vaccine development, while handing over the production and quality control of AAV vectors to professional service providers, thereby accelerating product research and development. and listing process.

This report studies the global AAV Vector CDMO Services demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for AAV Vector CDMO Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of AAV Vector CDMO Services that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global AAV Vector CDMO Services total market, 2018-2029, (USD Million)

Global AAV Vector CDMO Services total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: AAV Vector CDMO Services total market, key domestic companies and share, (USD Million)

Global AAV Vector CDMO Services revenue by player and market share 2018-2023, (USD Million)

Global AAV Vector CDMO Services total market by Type, CAGR, 2018-2029, (USD Million)

Global AAV Vector CDMO Services total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global AAV Vector CDMO Services market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Lonza, Catalent, Charles River, Merck, SK pharmteco, Oxford Biomedica, AGC Biologics(MolMed) and Gene Universal, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World AAV Vector CDMO Services market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global AAV Vector CDMO Services Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global AAV Vector CDMO Services Market, Segmentation by Type
Adherent Culture
Suspension Culture

Global AAV Vector CDMO Services Market, Segmentation by Application
Vaccine Development
Gene Therapy
Academic Scientific Research Institution
Others

Companies Profiled:
Thermo Fisher Scientific
Lonza
Catalent
Charles River
Merck
SK pharmteco
Oxford Biomedica
AGC Biologics(MolMed)
Gene Universal
Polyplus (Sartorius)
CCRM
FUJIFILM Diosynth Biotechnologies
Biovian
Miltenyi Bioindustry
Aldevron
Takara Bio
Yposkesi
Genezen
Exthera
GenScript ProBio
EurekaBio
Obio Technology
GeneSail Biotech
VectorBuilder
WuXi ATU
Ubrigene
Porton Biologics
Pharmaron
PackGene Biotechnology

Key Questions Answered

1. How big is the global AAV Vector CDMO Services market?

2. What is the demand of the global AAV Vector CDMO Services market?

3. What is the year over year growth of the global AAV Vector CDMO Services market?

4. What is the total value of the global AAV Vector CDMO Services market?

5. Who are the major players in the global AAV Vector CDMO Services market?


1 Supply Summary
2 Demand Summary
3 World AAV Vector CDMO Services Companies Competitive Analysis
4 United States VS China VS Rest of World (by Headquarter Location)
5 Market Analysis by Type
6 Market Analysis by Application
7 Company Profiles
8 Industry Chain Analysis
9 Research Findings and Conclusion
10 Appendix

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings